» Articles » PMID: 35842651

Noncoding RNAs As Sensors of Tumor Microenvironmental Stress

Overview
Publisher Biomed Central
Specialty Oncology
Date 2022 Jul 16
PMID 35842651
Authors
Affiliations
Soon will be listed here.
Abstract

The tumor microenvironment (TME) has been demonstrated to modulate the biological behavior of tumors intensively. Multiple stress conditions are widely observed in the TME of many cancer types, such as hypoxia, inflammation, and nutrient deprivation. Recently, accumulating evidence demonstrates that the expression levels of noncoding RNAs (ncRNAs) are dramatically altered by TME stress, and the dysregulated ncRNAs can in turn regulate tumor cell proliferation, metastasis, and drug resistance. In this review, we elaborate on the signal transduction pathways or epigenetic pathways by which hypoxia-inducible factors (HIFs), inflammatory factors, and nutrient deprivation in TME regulate ncRNAs, and highlight the pivotal roles of TME stress-related ncRNAs in tumors. This helps to clarify the molecular regulatory networks between TME and ncRNAs, which may provide potential targets for cancer therapy.

Citing Articles

Mechanisms and therapeutic implications of gene expression regulation by circRNA-protein interactions in cancer.

Zhang N, Wang X, Li Y, Lu Y, Sheng C, Sun Y Commun Biol. 2025; 8(1):77.

PMID: 39825074 PMC: 11748638. DOI: 10.1038/s42003-024-07383-z.


Adaptive Significance of Non-coding RNAs: Insights from Cancer Biology.

McDonald J Mol Biol Evol. 2025; 42(1).

PMID: 39761690 PMC: 11725524. DOI: 10.1093/molbev/msae269.


Targeting PGK1: A New Frontier in Breast Cancer Therapy Under Hypoxic Conditions.

Cui J, Chai S, Liu R, Shen G Curr Issues Mol Biol. 2024; 46(11):12214-12229.

PMID: 39590319 PMC: 11593045. DOI: 10.3390/cimb46110725.


A novel hypoxia-induced lncRNA, SZT2-AS1, boosts HCC progression by mediating HIF heterodimerization and histone trimethylation under a hypoxic microenvironment.

Liu R, Guo Y, Wang L, Yin G, Tuo H, Zhu Y Cell Death Differ. 2024; .

PMID: 39572656 DOI: 10.1038/s41418-024-01419-x.


LncRNAs in tumor metabolic reprogramming and tumor microenvironment remodeling.

Jiao J, Zhao Y, Li Q, Jin S, Liu Z Front Immunol. 2024; 15:1467151.

PMID: 39539540 PMC: 11557318. DOI: 10.3389/fimmu.2024.1467151.


References
1.
Wu J, Zhang J, Shen B, Yin K, Xu J, Gao W . Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition. J Exp Clin Cancer Res. 2015; 34:116. PMC: 4600266. DOI: 10.1186/s13046-015-0229-3. View

2.
Hu M, Fu Q, Jing C, Zhang X, Qin T, Pan Y . LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia. Biomed Pharmacother. 2020; 125:109703. DOI: 10.1016/j.biopha.2019.109703. View

3.
Zhu W, Chen X, Guo X, Liu H, Ma R, Wang Y . Low Glucose-Induced Overexpression of HOXC-AS3 Promotes Metabolic Reprogramming of Breast Cancer. Cancer Res. 2022; 82(5):805-818. DOI: 10.1158/0008-5472.CAN-21-1179. View

4.
Chen T, Li J, Zhou M, Xu L, Pan T . IL-6 stimulates lncRNA ZEB2-AS1 to aggravate the progression of non-small cell lung cancer through activating STAT1. Eur Rev Med Pharmacol Sci. 2020; 24(7):3734-3740. DOI: 10.26355/eurrev_202004_20837. View

5.
Yang C, Li K, Pfeffer S, Pfeffer L . The Type I IFN-Induced miRNA, miR-21. Pharmaceuticals (Basel). 2015; 8(4):836-47. PMC: 4695812. DOI: 10.3390/ph8040836. View